0122 ECP ONK
BioCentury & Getty Images

Emerging Company Profile

ONK’s CAR NK cells hit the TRAIL

Emerging Company Profile: Ireland’s ONK Therapeutics soups up CAR NK cells with TRAIL variants

With its TRAIL variants, Ireland’s ONK Therapeutics aims to increase the potency of and reduce resistance to its CAR NK cells. 

Jan 23, 2021 | 12:02 AM GMT

ONK thinks its engineered TRAIL variants will make CAR NK

Read the full 647 word article

How to gain access

Continue reading with a
two-week free trial.